How Does Omitting Additional Surgery After Local Excision Affect the Prognostic Outcome of Patients With High-risk T1 Colorectal Cancer?

医学 结直肠癌 倾向得分匹配 外科 入射(几何) 直肠 癌症 淋巴结 内科学 物理 光学
作者
Akira Ouchi,Koji Komori,Masahiro Tajika,Kazuhiro Toriyama,Yoshiki Kajiwara,Shiro Oka,Yosuke Fukunaga,Kinichi Hotta,Hiroaki Ikematsu,Shunsuke Tsukamoto,Shinji Nagata,Kazutaka Yamada,Maki Konno,Soichiro Ishihara,Yusuke Saitoh,Kenji Matsuda,Kazutomo Togashi,Megumi Ishiguro,Toshio Kuwai,Takashi Okuyama,Akihiro Ohuchi,Shinobu Ohnuma,Kazuhiro Sakamoto,Tamotsu Sugai,Kenji Katsumata,Hiro‐o Matsushita,Keisuke Nakai,Toshio Uraoka,Naohiko Akimoto,Hirotoshi Kobayashi,Yoichi Ajioka,Kenichi Sugihara,Hideki Ueno
出处
期刊:Annals of Surgery [Lippincott Williams & Wilkins]
被引量:6
标识
DOI:10.1097/sla.0000000000006092
摘要

Objective: To investigate how omitting additional surgery after local excision (LE) affects patient outcomes in high-risk T1 colorectal cancer (CRC). Summary Background Data: It is debatable whether additional surgery should be performed for all patients with high-risk T1 CRC regardless of the tolerability of invasive procedures. Methods: Patients who had received LE for T1 CRC at the Japanese Society for Cancer of the Colon and Rectum (JSCCR) institutions between 2009 and 2016 were analyzed. Those who had received additional surgical resection and who did not were matched one-on-one by the propensity score (PS)-matching method. A total of 401 PS-matched pairs were extracted from 1,975 patients at 27 JSCCR institutions and compared. Results: Regional lymph node metastasis was observed in 31 (7.7%) patients in the LE+surgery group. Comparatively, the incidence of oncologic adverse events was low in the LE-alone group, such as the 5-year cumulative risk of local recurrence (4.1%) or overall recurrence (5.5%). In addition, the difference in the 5-year CSS between the LE+surgery and LE-alone groups was only 1.8% (99.7% and 97.9%, respectively), whereas the 5-year OS was significantly lower in the LE-alone group than in the LE+surgery group (88.5% vs. 94.5%, respectively ( P =0.002). Conclusions: Those who had been decided to omit additional surgery at the dedicated center for CRC treatment presented a small number of oncologic events and a satisfactory CSS, which may suggest an important role of risk assessment regarding non-oncologic adverse events to achieve a best practice for each individual with high-risk T1 tumors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Asurary完成签到 ,获得积分10
2秒前
小唐完成签到,获得积分10
4秒前
4秒前
5秒前
无花果应助合适忆山采纳,获得20
6秒前
量子星尘发布了新的文献求助10
7秒前
asdfasdfj发布了新的文献求助10
7秒前
blueheavan发布了新的文献求助10
8秒前
NexusExplorer应助满意的天蓝采纳,获得10
9秒前
racill发布了新的文献求助10
10秒前
10秒前
风夏完成签到,获得积分10
12秒前
xukaixuan001发布了新的文献求助10
13秒前
糯米大王发布了新的文献求助10
13秒前
顾矜应助大锅菜采纳,获得10
13秒前
liaodongjun应助emilybei采纳,获得10
14秒前
大妙妙完成签到 ,获得积分10
15秒前
CodeCraft应助yyyq0721采纳,获得10
15秒前
thx完成签到,获得积分10
17秒前
19秒前
FashionBoy应助忧郁芹菜采纳,获得10
19秒前
ED应助超级面包采纳,获得10
20秒前
王丹靖发布了新的文献求助10
20秒前
deathmask完成签到 ,获得积分10
21秒前
22秒前
li完成签到,获得积分10
24秒前
SciGPT应助emilybei采纳,获得10
25秒前
27秒前
corazon完成签到,获得积分10
28秒前
温暖元容完成签到,获得积分10
29秒前
happylion完成签到,获得积分10
31秒前
blueheavan完成签到 ,获得积分10
32秒前
jhy完成签到,获得积分10
34秒前
Owen应助吃桂花的芒果采纳,获得10
34秒前
bkagyin应助林子青采纳,获得10
36秒前
37秒前
ttttsy完成签到 ,获得积分10
37秒前
Yuki完成签到 ,获得积分10
41秒前
z不停发布了新的文献求助10
42秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
Interpretation of Mass Spectra, Fourth Edition 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3951098
求助须知:如何正确求助?哪些是违规求助? 3496497
关于积分的说明 11082428
捐赠科研通 3226957
什么是DOI,文献DOI怎么找? 1784092
邀请新用户注册赠送积分活动 868183
科研通“疑难数据库(出版商)”最低求助积分说明 801069